{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:45:44Z","timestamp":1791618344225,"version":"4.3.4"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Prolactin is a polypeptide hormone that is well known for its role in reproductive physiology. Recent studies highlight its role in neurohormonal appetite regulation and metabolism. Elevated prolactin levels are widely associated with worsening metabolic disease, but it appears that low prolactin levels could also be metabolically unfavorable. This review discusses the pathophysiology of prolactin related metabolic changes, and the less commonly recognized effects of prolactin on adipose tissue, pancreas, liver, and small bowel. Furthermore, the effect of dopamine agonists on the metabolic profiles of patients with hyperprolactinemia are discussed as well.<\/jats:p>","DOI":"10.3389\/fendo.2022.1002320","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T07:35:45Z","timestamp":1664523345000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":71,"title":["Metabolic effects of prolactin and the role of dopamine agonists: A review"],"prefix":"10.3389","volume":"13","author":[{"given":"Polly","family":"Kirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kunadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.01.004","article-title":"Time for a new perspective on prolactin in metabolism","volume":"31","author":"Macotela","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: Structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol Rev"},{"key":"B3","article-title":"Physiology, prolactin","volume-title":"Statpearls","author":"Al-Chalabi","year":"2022"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2014.02.001","article-title":"Tidal waves: Network mechanisms in the neuroendocrine control of prolactin release","volume":"35","author":"Lyons","year":"2014","journal-title":"Front Neuroendocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)36838-2","article-title":"Tissue distribution and regulation of rat prolactin receptor gene expression","volume":"269","author":"Nagano","year":"1994","journal-title":"Quant Anal by Polymerase Chain React J Biol Chem"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e12888","DOI":"10.1111\/jne.12888","article-title":"Metabolic functions of prolactin: Physiological and pathological aspects","volume":"32","author":"Lopez-Vicchi","year":"2020","journal-title":"J Neuroendocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2006.02.005","article-title":"Focus on prolactin as a metabolic hormone","volume":"17","author":"Ben-Jonathan","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1055\/s-0031-1284353","article-title":"Prolactin and lactation as modifiers of diabetes risk in gestational diabetes","volume":"43","author":"Ramos-Rom\u00e1n","year":"2011","journal-title":"Horm Metab Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-1003","article-title":"Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy","volume":"150","author":"Huang","year":"2009","journal-title":"Endocrinology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.2.7979","article-title":"Body weight and fat deposition in prolactin receptor-deficient mice","volume":"142","author":"Freemark","year":"2001","journal-title":"Endocrinology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02170-x","article-title":"Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans","volume":"67","author":"Ponce","year":"2020","journal-title":"Endocrine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: An endocrine society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: A community-based, cross-sectional study in Banbury (Oxfordshire, uk)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0157-3","article-title":"The effects of novel and newly approved antipsychotics on serum prolactin levels: A comprehensive review","volume":"28","author":"Peuskens","year":"2014","journal-title":"CNS Drugs"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpsm.2015.11.003","article-title":"Spanish Consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia","volume":"9","author":"Montejo","year":"2016","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122203","article-title":"Hyperprolactinaemia","volume":"8","author":"Samperi","year":"2019","journal-title":"J Clin Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/eje-14-0013","article-title":"Therapy of endocrine disease: The challenges in managing giant prolactinomas","volume":"170","author":"Maiter","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/eje-17-0505","article-title":"Diagnosis of endocrine disease: Primary empty sella: A comprehensive review","volume":"177","author":"Chiloiro","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4065\/80.8.1050","article-title":"Medication-induced hyperprolactinemia","volume":"80","author":"Molitch","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.psym.2013.08.008","article-title":"Psychotropic-induced hyperprolactinemia: A clinical review","volume":"55","author":"Ajmal","year":"2014","journal-title":"Psychosomatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.07.012","article-title":"Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism","volume":"35","author":"Sharma","year":"2016","journal-title":"Eur J Intern Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9253083","article-title":"Stress-induced hyperprolactinemia: Pathophysiology and clinical approach","volume":"2018","author":"Levine","year":"2018","journal-title":"Obstet Gynecol Int"},{"key":"B24","article-title":"Diagnosis of stress-related hyperprolactinemia. evaluation of the hyperprolactinemia rest test","volume":"89","author":"Muneyyirci-Delale","year":"1989","journal-title":"N Y State J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12489","article-title":"Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis","volume":"21","author":"Lo","year":"2017","journal-title":"Hemodial Int"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1530\/eje-18-0270","article-title":"Mechanisms of endocrinology: Endocrinology of opioids","volume":"179","author":"Fountas","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c140029","article-title":"Neuroendocrine regulation of lactation and milk production","volume":"5","author":"Crowley","year":"2015","journal-title":"Compr Physiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2017\/24730.10273","article-title":"Correlation of serum prolactin level to child pugh scoring system in cirrhosis of liver","volume":"11","author":"Balakrishnan","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.00859.x","article-title":"Hyperprolactinaemia and verapamil: Prevalence and potential association with hypogonadism in men","volume":"45","author":"Romeo","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1590\/0004-2730000003002","article-title":"Challenges and pitfalls in the diagnosis of hyperprolactinemia","volume":"58","author":"Vilar","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0075","article-title":"Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: Implications for ohss development and treatment","volume":"96","author":"G\u00f3mez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0655-1","article-title":"Is prolactin the missing link in adipose tissue dysfunction of polycystic ovary syndrome patients","volume":"51","author":"Albu","year":"2016","journal-title":"Endocrine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.seizure.2017.02.013","article-title":"The role of postictal laboratory blood analyses in the diagnosis and prognosis of seizures","volume":"47","author":"Nass","year":"2017","journal-title":"Seizure"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.1999.0284","article-title":"Serum prolactin levels after seizure and syncopal attacks","volume":"8","author":"Lusi\u0107","year":"1999","journal-title":"Seizure"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02744-8","article-title":"Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas","volume":"74","author":"Wright","year":"2021","journal-title":"Endocrine"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02627.x","article-title":"Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? a study of 226 patients with histologically verified non-functioning pituitary macroadenoma","volume":"65","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7462","article-title":"Role of Prolactin\/Adenoma maximum diameter and Prolactin\/Adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas","volume":"15","author":"Huang","year":"2018","journal-title":"Oncol Lett"},{"key":"B38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11102-008-0097-3","article-title":"The effects of hyperprolactinemia on bone and fat","volume":"12","author":"Shibli-Rahhal","year":"2009","journal-title":"Pituitary"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1989.256.1.R276","article-title":"Prolactin stimulates food intake in a dose-dependent manner","volume":"256","author":"Gerardo-Gettens","year":"1989","journal-title":"Am J Physiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2020.09.001","article-title":"Association between prolactinoma and body mass index","volume":"27","author":"Al Sabie","year":"2021","journal-title":"Endocr Pract"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0194-6","article-title":"Prolactin - a pleiotropic factor in health and disease","volume":"15","author":"Bernard","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/js.2017-00328","article-title":"Hypothalamic-Pituitary-Ovarian axis reactivation by kisspeptin-10 in hyperprolactinemic women with chronic amenorrhea","volume":"1","author":"Millar","year":"2017","journal-title":"J Endocr Soc"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac166","article-title":"Kisspeptin overcomes gnrh neuronal suppression secondary to hyperprolactinemia in humans","volume":"107","author":"Hoskova","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0668","article-title":"Identification of prolactin-sensitive gaba and kisspeptin neurons in regions of the rat hypothalamus involved in the control of fertility","volume":"152","author":"Kokay","year":"2011","journal-title":"Endocrinology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0363-7","article-title":"Metabolic regulation of kisspeptin - the link between energy balance and reproduction","volume":"16","author":"Navarro","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00184","article-title":"The emerging Role(S) for kisspeptin in metabolism in mammals","volume":"9","author":"Wolfe","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.03.005","article-title":"Glucagon regulates hepatic kisspeptin to impair insulin secretion","volume":"19","author":"Song","year":"2014","journal-title":"Cell Metab"},{"key":"B48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12020-017-1248-y","article-title":"Kisspeptin-10 inhibits proliferation and regulates lipolysis and lipogenesis processes in 3t3-L1 cells and isolated rat adipocytes","volume":"56","author":"Pruszy\u0144ska-Oszma\u0142ek","year":"2017","journal-title":"Endocrine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e113020","DOI":"10.1371\/journal.pone.0113020","article-title":"Differential stimulation of insulin secretion by glp-1 and kisspeptin-10","volume":"9","author":"Schwetz","year":"2014","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/me.2015-1232","article-title":"Minireview: Cns mechanisms of leptin action","volume":"30","author":"Flak","year":"2016","journal-title":"Mol Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab025","article-title":"Arcuate nucleus-dependent regulation of metabolism-pathways to obesity and diabetes mellitus","volume":"43","author":"Jais","year":"2022","journal-title":"Endocr Rev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S182406","article-title":"Leptin resistance: Underlying mechanisms and diagnosis","volume":"12","author":"Gruzdeva","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00109","article-title":"Running from disease: Molecular mechanisms associating dopamine and leptin signaling in the brain with physical inactivity, obesity, and type 2 diabetes","volume":"8","author":"Ruegsegger","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801291","article-title":"Physiopathology of prolactin secretion in obesity","author":"Kopelman","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0338","article-title":"Region-specific reduction in leptin-induced phosphorylation of signal transducer and activator of transcription-3 (Stat3) in the rat hypothalamus is associated with leptin resistance during pregnancy","volume":"145","author":"Ladyman","year":"2004","journal-title":"Endocrinology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0442","article-title":"Prolactin\/Leptin interactions in the control of food intake in rats","volume":"148","author":"Naef","year":"2007","journal-title":"Endocrinology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)03643-6","article-title":"Brain dopamine and obesity","volume":"357","author":"Wang","year":"2001","journal-title":"Lancet"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/s0188-4409(00)00059-x","article-title":"Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome","volume":"31","author":"Hern\u00e1ndez","year":"2000","journal-title":"Arch Med Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu133","article-title":"Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome","volume":"29","author":"Glintborg","year":"2014","journal-title":"Hum Reprod"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00263","article-title":"The association between prolactin and metabolic parameters in pcos women: A retrospective analysis","volume":"11","author":"Yang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032184","article-title":"Prolactin release is enhanced in proportion to excess visceral fat in obese women","volume":"89","author":"Kok","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2006.10955","article-title":"Increased prevalence of high body mass index in patients presenting with pituitary tumours: Severe obesity in patients with macroprolactinoma","volume":"136","author":"Schmid","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"B63","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/bf00745135","article-title":"Prolactin: A diabetogenic hormone","volume":"13","author":"Landgraf","year":"1977","journal-title":"Diabetologia"},{"key":"B64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2265.1991.tb03503.x","article-title":"An association between hypothalamic-pituitary dysfunction and peripheral endocrine function in extreme obesity","volume":"35","author":"Weaver","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11154-019-09503-1","article-title":"Prolactin and human weight disturbances: A puzzling and neglected association","volume":"20","author":"Sobrinho","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00403.x","article-title":"Increased body weight associated with prolactin secreting pituitary adenomas: Weight loss with normalization of prolactin levels","volume":"48","author":"Greenman","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1530\/ec-21-0040","article-title":"Circulating prolactin level is increased in metabolically healthy obesity","volume":"10","author":"Liu","year":"2021","journal-title":"Endocr Connect"},{"key":"B68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1210\/en.2016-1444","article-title":"Prolactin promotes adipose tissue fitness and insulin sensitivity in obese males","volume":"158","author":"Ruiz-Herrera","year":"2017","journal-title":"Endocrinology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k06-026","article-title":"Hypoadiponectinemia in lean lactating women: Prolactin inhibits adiponectin secretion from human adipocytes","volume":"53","author":"Asai-Sato","year":"2006","journal-title":"Endocr J"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.04.026","article-title":"Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue","volume":"331","author":"Nilsson","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.765976","article-title":"Prolactin-induced adaptation in glucose homeostasis in mouse pregnancy is mediated by the pancreas and not in the forebrain","volume":"12","author":"Khant Aung","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1210\/endo-45-6-627","article-title":"Diabetogenic action of purified anterior pituitary hormones","volume":"45","author":"Houssay","year":"1949","journal-title":"Endocrinology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1630229","article-title":"Prolactin protects against diabetes induced by multiple low doses of streptozotocin in mice","volume":"163","author":"Holstad","year":"1999","journal-title":"J Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.2337\/diab.43.2.263","article-title":"Regulation of islet beta-cell proliferation by prolactin in rat islets","volume":"43","author":"Brelje","year":"1994","journal-title":"Diabetes"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-022-20445-1","article-title":"Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus","volume":"29","author":"Kabir","year":"2022","journal-title":"Environ Sci pollut Res Int"},{"key":"B76","doi-asserted-by":"publisher","first-page":"E62","DOI":"10.1152\/ajpendo.00325.2019","article-title":"Bromocriptine improves glucose tolerance independent of circadian timing, prolactin, or the melanocortin-4 receptor","volume":"318","author":"Framnes-DeBoer","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0b013e318229d2d2","article-title":"Bromocriptine for diabetes mellitus type ii","volume":"19","author":"Valiquette","year":"2011","journal-title":"Cardiol Rev"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0064","article-title":"Bromocriptine: A sympatholytic, D2-dopamine agonist for the treatment of type 2 diabetes","volume":"34","author":"Defronzo","year":"2011","journal-title":"Diabetes Care"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-013-0493-7","article-title":"Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans","volume":"51","author":"Wagner","year":"2014","journal-title":"Acta Diabetol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1215","article-title":"Serum prolactin concentrations determine whether they improve or impair \u03b2-cell function and insulin sensitivity in diabetic rats","volume":"27","author":"Park","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1159\/000336501","article-title":"Central prolactin modulates insulin sensitivity and insulin secretion in diabetic rats","volume":"95","author":"Park","year":"2012","journal-title":"Neuroendocrinology"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1404267111","article-title":"Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-myc in mice","volume":"111","author":"Hartwell","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.03.048","article-title":"Ablation of prolactin receptor increases hepatic triglyceride accumulation","volume":"498","author":"Shao","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.01.035","article-title":"Prolactin improves hepatic steatosis Via Cd36 pathway","volume":"68","author":"Zhang","year":"2018","journal-title":"J Hepatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0182","article-title":"Prlr regulates hepatic insulin sensitivity in mice Via Stat5","volume":"62","author":"Yu","year":"2013","journal-title":"Diabetes"},{"key":"B86","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1079\/bjn19750005","article-title":"The effect of pregnancy and lactation on food intake, gastrointestinal anatomy and the absorptive capacity of the small intestine in the albino rat","volume":"33","author":"Cripps","year":"1975","journal-title":"Br J Nutr"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1023\/a:1026332304435","article-title":"Adaptation of the maternal intestine during lactation","volume":"2","author":"Hammond","year":"1997","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1136\/gut.22.7.558","article-title":"Prolactin and the small intestine. effect of hyperprolactinaemia on mucosal structure in the rat","volume":"22","author":"Muller","year":"1981","journal-title":"Gut"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2174\/092986612801619633","article-title":"Influence of prolactin and calcium gluconate concentration on permeation and intestinal absorption of Ca(Ii) ions","volume":"19","author":"Ryszka","year":"2012","journal-title":"Protein Pept Lett"},{"key":"B90","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12902-021-00733-6","article-title":"Adverse body composition and lipid parameters in patients with prolactinoma: A case-control study","volume":"21","author":"Posawetz","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.769744","article-title":"Effects of pituitary surgery and high-dose cabergoline therapy on metabolic profile in patients with prolactinoma resistant to conventional cabergoline treatment","volume":"12","author":"Pirchio","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2021.100258","article-title":"Impact of primary medical or surgical therapy on prolactinoma patients' bmi and metabolic profile over the long-term","volume":"24","author":"Andereggen","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e17824","DOI":"10.7759\/cureus.17824","article-title":"Change in insulin sensitivity and lipid profile after dopamine agonist therapy in patients with prolactinoma","volume":"13","author":"Khalil","year":"2021","journal-title":"Cureus"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-016-9882-2","article-title":"Treatment of hyperprolactinaemia reduces total cholesterol and ldl in patients with prolactinomas","volume":"32","author":"Schwetz","year":"2017","journal-title":"Metab Brain Dis"},{"key":"B95","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000371851","article-title":"Effect of chronic cabergoline treatment and testosterone replacement on metabolism in Male patients with prolactinomas","volume":"101","author":"Auriemma","year":"2015","journal-title":"Neuroendocrinology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2015.01.024","article-title":"Risk factors for accelerated atherosclerosis in young women with hyperprolactinemia","volume":"84","author":"Medic-Stojanoska","year":"2015","journal-title":"Med Hypotheses"},{"key":"B97","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13098-015-0094-4","article-title":"Metabolic abnormalities in patients with prolactinoma: Response to treatment with cabergoline","volume":"7","author":"Pala","year":"2015","journal-title":"Diabetol Metab Syndr"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0524-y","article-title":"Prevalence of obstructive sleep apnea in patients with prolactinoma before and after treatment with dopamine agonists","volume":"17","author":"Barbosa","year":"2014","journal-title":"Pituitary"},{"key":"B99","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000357810","article-title":"Effect of cabergoline on metabolism in prolactinomas","volume":"98","author":"Auriemma","year":"2013","journal-title":"Neuroendocrinology"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12204","article-title":"Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels","volume":"79","author":"Ciresi","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9857-y","article-title":"Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma","volume":"44","author":"Inancli","year":"2013","journal-title":"Endocrine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","article-title":"Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy","volume":"14","author":"Berinder","year":"2011","journal-title":"Pituitary"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2010.150","article-title":"Bmi and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists","volume":"19","author":"dos Santos Silva","year":"2011","journal-title":"Obes (Silver Spring)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02469.x","article-title":"The influences of hyperprolactinemia and obesity on cardiovascular risk markers: Effects of cabergoline therapy","volume":"64","author":"Serri","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490187","article-title":"Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women","volume":"149","author":"Yavuz","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1530\/eje.0.1470077","article-title":"Dopaminergic tone and obesity: An insight from prolactinomas treated with bromocriptine","volume":"147","author":"Doknic","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1893","article-title":"Circulating prolactin associates with diabetes and impaired glucose regulation: A population-based study","volume":"36","author":"Wang","year":"2013","journal-title":"Diabetes Care"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-13-12","article-title":"Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes","volume":"13","author":"Balbach","year":"2013","journal-title":"BMC Endocr Disord"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.07.007","article-title":"An investigation of the association between the level of prolactin in serum and type ii diabetes","volume":"13","author":"Manshaei","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03145-1","article-title":"Cardiometabolic profile of young women with hypoprolactinemia","volume":"78","author":"Krysiak","year":"2022","journal-title":"Endocrine"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.endien.2021.03.004","article-title":"Sexual function and depressive symptoms in men with hypoprolactinaemia secondary to overtreatment of prolactin excess: A pilot study","volume":"69","author":"Krysiak","year":"2022","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4733-9","article-title":"Circulating prolactin concentrations and risk of type 2 diabetes in us women","volume":"61","author":"Li","year":"2018","journal-title":"Diabetologia"},{"key":"B113","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/aje\/kwv326","article-title":"Circulating prolactin and risk of type 2 diabetes: A prospective study","volume":"184","author":"Wang","year":"2016","journal-title":"Am J Epidemiol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.0293-15.2015","article-title":"Dopamine\/Tyrosine hydroxylase neurons of the hypothalamic arcuate nucleus release gaba, communicate with dopaminergic and other arcuate neurons, and respond to dynorphin, met-enkephalin, and oxytocin","volume":"35","author":"Zhang","year":"2015","journal-title":"J Neurosci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1002320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T07:35:50Z","timestamp":1664523350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1002320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":114,"alternative-id":["10.3389\/fendo.2022.1002320"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1002320","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"article-number":"1002320"}}